SSTR-RADS 1.0标准化报告系统在生长抑素受体PET/CT中的观察者间一致性高
本研究在多中心随机设置中评估SSTR-RADS 1.0对68Ga-DOTATOC PET/CT判读的观察者间信度,4名不同经验读者独立评估51例扫描。结果显示基于病灶、器官和整体扫描的SSTR-RADS评分一致性良好至优秀,基于SSTR-RADS的PRRT决策一致性优秀,经验不同读者间无显著差异。
要点
- SSTR-RADS整体扫描印象的观察者间一致性优秀(ICC 0.88)。
- 基于SSTR-RADS的PRRT决策一致性优秀(ICC 0.80)。
- 经验与无经验读者间整体印象和病灶评分无显著差异(P≥0.18)。
核心结论
- SSTR-RADS引导的评估显示高一致性,支持将其用于试验、临床常规或结局研究。
研究设计与样本
- 多中心随机设置中,51例随机68Ga-DOTATOC PET/CT扫描由4名设盲读者独立评估,其中2名有经验、2名无经验,均接受SSTR-RADS 1.0标准培训。
主要发现
- 至少2名读者选择的靶病灶中153个被选中,4名读者选择相同靶病灶的情况占58/153(37.9%)。
- 相同靶病灶间SSTR-RADS评分的观察者间一致性良好,4个、3个和2个相同靶病灶的ICC均≥0.73。
- 淋巴结和肝脏病灶的观察者间一致性优秀,ICC分别为0.91和0.77。
- 整体扫描印象基于SSTR-RADS的观察者间一致性优秀(ICC 0.88)。
- 基于SSTR-RADS的PRRT决策一致性优秀(ICC 0.80),有经验与无经验读者间整体印象和病灶评分无显著差异(P≥0.18)。
关键数值与推荐
- SSTR-RADS 1.0基于5分制:1分为明确良性,5分为高度确定存在神经内分泌肿瘤。
- 每例扫描最多对5个靶病灶分配SSTR-RADS评分,并给出基于SSTR-RADS的整体扫描印象。
临床怎么用
- SSTR-RADS 1.0可用于标准化判读生长抑素受体PET/CT,且不同经验读者均可应用。
- 基于SSTR-RADS评分可辅助决定是否考虑肽受体放射性核素治疗(PRRT)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recently, a standardized framework system for interpreting somatostatin receptor (SSTR)-targeted PET/CT, termed the SSTR reporting and data system (RADS) 1.0, was introduced, providing reliable standards and criteria for SSTR-targeted imaging. We determined the interobserver reliability of SSTR-RADS for interpretation of 68Ga-DOTATOC PET/CT scans in a multicentric, randomized setting. Methods: A set of 51 randomized 68Ga-DOTATOC PET/CT scans was independently assessed by 4 masked readers with different levels of experience (2 experienced readers and 2 inexperienced readers) trained on the SSTR-RADS 1.0 criteria (based on a 5-point scale from 1 [definitively benign] to 5 [high certainty that neuroendocrine neoplasia is present]). For each scan, SSTR-RADS scores were assigned to a maximum of 5 target lesions (TLs). An overall scan impression based on SSTR-RADS was indicated, and interobserver agreement rates on a TL-based, on an organ-based, and on an overall SSTR-RADS score-based level were computed. The readers were also asked to decide whether peptide receptor radionuclide therapy (PRRT) should be considered on the basis of the assigned RADS scores. Results: Among the selected TLs, 153 were chosen by at least 2 readers (all 4 readers selected the same TLs in 58 of 153 [37.9%] instances). The interobserver agreement for SSTR-RADS scoring among identical TLs was good (intraclass correlation coefficient [ICC] ≥ 0.73 for 4, 3, and 2 identical TLs). For lymph node and liver lesions, excellent interobserver agreement rates were derived (ICC, 0.91 and 0.77, respectively). Moreover, the interobserver agreement for an overall scan impression based on SSTR-RADS was excellent (ICC, 0.88). The SSTR-RADS-based decision to use PRRT also demonstrated excellent agreement, with an ICC of 0.80. No significant differences between experienced and inexperienced readers for an overall scan impression and TL-based SSTR-RADS scoring were observed (P ≥ 0.18), thereby suggesting that SSTR-RADS seems to be readily applicable even for less experienced readers. Conclusion: SSTR-RADS-guided assessment demonstrated a high concordance rate, even among readers with different levels of experience, supporting the adoption of SSTR-RADS for trials, clinical routine, or outcome studies.
引用
- Werner RA, Derlin T, Rowe SP, et al. High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT. J Nucl Med. 2020. PMID: 32859702. doi:10.2967/jnumed.120.245464
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。